Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial

Burman, M; Copas, A; Zenner, D; Hickson, V; Gosce, L; Trathen, D; Ashcroft, R; Martineau, AR; Abubakar, I; Griffiths, C; Kunst, H

Journal article

Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial

Abstract:: BACKGROUND: The identification and treatment of LTBI is a key component of the WHO's strategy to eliminate TB. Recent migrants from high TB-incidence countries are recognised to be at risk TB reactivation, and many high-income countries have focused on LTBI screening and treatment programmes for this group. However, migrants are the group least likely to complete the LTBI cascade-of-care. This pragmatic cluster-randomised, parallel group, superiority trial investigates whether a model of care based entirely within a community setting (primary care) will improve treatment completion compared with treatment in specialist TB services (secondary care). METHODS: The CATAPuLT trial (Completion and Acceptability of Treatment Across Primary Care and the community for Latent Tuberculosis) randomised 34 general practices in London, England, to evaluate the efficacy and safety of treatment for LBTI in recent migrants within primary care. GP practices were randomised to either provide management for LTBI entirely within primary care (GPs and community pharmacists) or to refer patients to secondary care. The target recruitment number for individuals is 576. The primary outcome is treatment completion (defined as taking at least 90% of antibiotic doses). The secondary outcomes assess adherence, acceptance of treatment, the incidence of adverse effects including drug-induced liver injury, the rates of active TB, patient satisfaction and cost-effectiveness of LTBI treatment. This protocol adheres to the SPIRIT Checklist. DISCUSSION: The CATAPuLT trial seeks to provide implementation research evidence for a patient-centred intervention to improve treatment completion for LTBI amongst recent migrants to the UK. TRIAL REGISTRATION: NCT03069807, March 2017, registered retrospectively

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Burman, M., Copas, A., Zenner, D., Hickson, V., Gosce, L., Trathen, D., Ashcroft, R., Martineau, A. R., Abubakar, I., Griffiths, C., & Kunst, H. (2019). Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial. BMC Public Health, 19(1), 1598–1598.

MLA Style

Burman, M, et al. “Protocol for a Cluster Randomised Control Trial Evaluating the Efficacy and Safety of Treatment for Latent Tuberculosis Infection in Recent Migrants within Primary Care: the CATAPuLT Trial.” BMC Public Health, vol. 19, no. 1, 2019, pp. 1598–98.

Chicago Style

Burman, M, A Copas, D Zenner, et al. 2019. “Protocol for a Cluster Randomised Control Trial Evaluating the Efficacy and Safety of Treatment for Latent Tuberculosis Infection in Recent Migrants within Primary Care: the CATAPuLT Trial.” BMC Public Health 19 (1): 1598–98.
Print